Bovine Tuberculosis (bTB) roadmap:
Vaccines
Roadmap for the development of candidate vaccine for bTB
Download bTB-Vaccine-Roadmap1
Vaccine
Dependencies
- 2 Naturally attenuated candidates
- 2A Safety
- 2B Delivery route
- 2C Delivery platform
- 2D Efficacy in challenge model
- 3 Rationally attenuated candidates
- 3A Safety
- 3B Delivery route
- 3C Delivery platform
- 3D Efficacy in challenge model
- 4 Inactivated Vaccines
- 4A Safety
- 4B Delivery route
- 4C Delivery platform
- 4D Efficacy in challenge model
- 5 DNA/RNA vaccines
- 5A Safety
- 5B Delivery route
- 5C Delivery platform
- 5D Efficacy in challenge model
- 6 Subunit vaccines
- 6A Safety
- 6B Delivery route
- 6C Delivery platform
- 6D Efficacy in challenge model
- 7 Vectored vaccines
- 7A Safety
- 7B Delivery route
- 7C Delivery platform
- 7D Efficacy in challenge model
bTb vaccine
Research Question
What are we trying to achieve and why? What is the problem we are trying to solve?
The development of an effective vaccine against bTB, reducing R0 to <1 and allowing vaccinated to be differentiated
from infected
Research Gaps and Challenges
What are the scientific and technological challenges
(knowledge gaps needing to be addressed)?
- Vaccines can sensitise animals to current diagnostic tests resulting in false positives.
- The current BCG vaccine needs to be validated
- Availability of a standardised BCG
- The development of a better vaccine based on the rational attenuation of the organism or on purified immunogens delivered by various mechanisms
Solution Routes
What approaches could/should be taken to address the research question?
- Establish protection levels with various candidate vaccine options, including priming with one vaccine and boosting with a different vaccine.
- In particular establishing the level of protection given by BCG vaccination as a base line to compare other vaccines with Establish if bovine genetics influences responses
Dependencies
What else needs to be done before we can solve this need?
- Validation of BCG
- Development of a novel attenuated vaccine that isn’t excreted
- Development of a subunit vaccine
- Development of a DNA vaccine
- Development of a cross protective vectored vaccine
State Of the Art
Existing knowledge including successes and failures
Projects
What activities are planned or underway?
The use of microRNA expression profiling in the detection and prediction of Bovine Tuberculosis
Planned Completion date 01/01/2025
Source Countries:
United Kingdom